Natixis Invests $2.19 Million in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Natixis bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 27,979 shares of the company's stock, valued at approximately $2,187,000.

Other hedge funds have also recently modified their holdings of the company. Norges Bank bought a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $488,531,000. Capital Research Global Investors increased its position in shares of GE HealthCare Technologies by 4.5% in the 4th quarter. Capital Research Global Investors now owns 60,832,004 shares of the company's stock valued at $4,755,851,000 after acquiring an additional 2,608,066 shares during the period. Van ECK Associates Corp raised its stake in shares of GE HealthCare Technologies by 107.3% in the fourth quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock worth $378,520,000 after purchasing an additional 2,506,417 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of GE HealthCare Technologies by 4.3% in the 4th quarter. Vanguard Group Inc. now owns 52,537,446 shares of the company's stock valued at $4,107,378,000 after acquiring an additional 2,155,429 shares during the last quarter. Finally, Invesco Ltd. raised its stake in shares of GE HealthCare Technologies by 18.4% during the 4th quarter. Invesco Ltd. now owns 8,067,927 shares of the company's stock valued at $630,751,000 after buying an additional 1,252,613 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on GEHC shares. Citigroup increased their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. The Goldman Sachs Group raised GE HealthCare Technologies from a "neutral" rating to a "buy" rating and raised their target price for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. BTIG Research set a $95.00 price target on shares of GE HealthCare Technologies and gave the stock a "buy" rating in a research report on Monday, April 14th. Finally, Piper Sandler reduced their price target on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a research report on Wednesday. One analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $96.50.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC traded up $1.34 during mid-day trading on Friday, hitting $68.42. The stock had a trading volume of 5,508,561 shares, compared to its average volume of 3,258,510. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The stock has a market capitalization of $31.33 billion, a price-to-earnings ratio of 15.80, a P/E/G ratio of 3.19 and a beta of 1.14. The company has a 50 day simple moving average of $76.59 and a 200-day simple moving average of $82.19. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.20%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.